KCM
BVS icon

Kennedy Capital Management’s Bioventus BVS Stock Holding History

Kennedy Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.4M Sell
466,563
-8,408
-2% -$80.3K 0.08% 347
2026
Q1 		$4.34M Buy
474,971
+12,412
+3% +$104K 0.09% 321
2025
Q4 		$3.44M Buy
462,559
+980
+0.2% +$7.04K 0.07% 359
2025
Q3 		$3.09M Buy
461,579
+317,157
+220% +$2.2M 0.07% 376
2025
Q2 		$956K Buy
144,422
+21,463
+17% +$152K 0.02% 512
2025
Q1 		$1.13M Sell
122,959
-91,025
-43% -$909K 0.03% 496
2024
Q4 		$2.25M Buy
213,984
+95,266
+80% +$1.13M 0.05% 496
2024
Q3 		$1.42M Buy
118,718
+28,427
+31% +$246K 0.03% 560
2024
Q2 		$519K Sell
90,291
-29,843
-25% -$164K 0.01% 637
2024
Q1 		$625K Buy
120,134
+48,111
+67% +$235K 0.01% 645
2023
Q4 		$380K Buy
72,023
+5,467
+8% +$21.6K 0.01% 645
2023
Q3 		$220K Buy
+66,556
New +$234K 0.01% 650

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kennedy Capital Management's BVS Position: Q2 2026 in Review

Kennedy Capital Management reduced its Bioventus (BVS) stake by 1.8% in Q2 2026, selling an estimated $80.3K and leaving 466,563 shares worth $4.4M. The position accounts for 0.08% of the portfolio, ranked #347.

Kennedy Capital Management first reported a position in BVS in Q3 2023 and has held it in 12 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Kennedy Capital Management held 466,563 shares of Bioventus worth $4.4M as of Q2 2026.
  • Kennedy Capital Management sold 8,408 Bioventus shares in Q2 2026, an estimated $80.3K.
  • Bioventus made up 0.08% of Kennedy Capital Management's portfolio in Q2 2026, its #347 holding.
  • Kennedy Capital Management first reported a position in Bioventus in Q3 2023 and has held it in 12 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.